Letter: cytokeratin‐18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization1. Zhang C-Y, He Z-H, Ahir B-K, Luo C-P, Peng N-F, Li L-Q. Letter: should anti-viral therapy be recommended for individuals chronically infected with hepatitis B virus and at...
Proteomic analysis to identify cytokeratin 18 as a novel biomarker of nasopharyngeal carcinoma[J]. J Cancer Res Clin Oncol, 2009, 135(12): 1763-1775.Li, X.M.; Huang, W.G.; Yi, H.; Cheng, A.L.; Xiao, Z.Q. Proteomic analysis to identify cytokeratin 18 as a novel biomarker of ...
With a widening arsenal of cancer therapies available, it is important to develop therapy-specific predictive markers and methods to rapidly assess treatment efficacy. We here evaluated the use of cytokeratin-18 (CK18) as a serum biomarker for monitoring chemotherapy-induced cell death in breast can...
First described in 1965, it has become the most widely used biomarker in gastrointestinal malignancy (Hostetter et al, 1990) and can be measured quantitatively by an immunoradiometric assay in serum, but owing to its lack of sensitivity in the early stages of disease it is unsuitable for ...
Determining tumor apoptosis and necrosis in patient serum using cytokeratin 18 as a biomarker Stig Linder, ... Maria C. Shoshan, in Cancer Letters, 2004 Cytokeratins are members of the family of intermediate filament proteins and are found primarily in epithelial cells [41]. Type I cytokeratin...
Serum Cytokeratin-18 as a Non-invasive Biomarker and its Association with Biochemical Parameters in the Diagnosis of Non-alcoholic Fatty Liver Disease Objective: Nonalcoholic fatty liver disease (NAFLD) is one of the chronic silent diseases in which its therapeutic options and noninvasive markers of...
Moreover, the expression of MUC5AC was correlated with the degree of tumor differentiation in adenocarcinomas (P = 0.036) and was not related to the prognosis of cervical adenocarcinoma and subtypes. Conclusions MUC5AC may be useful as a biomarker for differential diagnoses between squamous ...
Multi-level evidence that circulating CK18 is a biomarker of tumour burden in colorectal cancer Background: Circulating total cytokeratin 18 (tCK1 Greystoke,A.,Dean,... - 《British Journal of Cancer》 被引量: 32发表: 2012年 Increased levels of antibodies to cytokeratin 18 in patients with rhe...
A potential biomarker hsa-miR-200a-5p distinguishing between benign thyroid tumors with papillary hyperplasia and papillary thyroid carcinoma PLoS One, 13 (2018), Article e0200290 CrossrefView in ScopusGoogle Scholar [120] D.S. Yoon, J. Jeong, Y.N. Park, et al. Expression of biliary antige...
erreichen. F�r diagnostische Zwecke steht dabei die zuverl�ssige Korrelation von Krankheitsgeschehen (Entz�ndung, Sepsis) mit dem jeweiligen Biomarker im Vordergrund, ohne dass dessen Rolle in der komplexen Kaskade der am Entz�ndungsgeschehen beteiligten endogenen Substanzen bekannt sein...